Sunday, September 24, 2023
In accordance with the ACCME’s Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 24 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.
Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Director, Crohn's & Colitis Center
Professor of Medicine
Professor of Microbiology and Immunology
Vice Chair for Research, Department of Medicine
Chair, IOIBD
University of Miami Miller School of Medicine
Miami, Florida
Assistant Professor of Medicine
Director of Translational Studies for the Crohn's and Colitis Center
Division of Gastroenterology
University of Miami Miller School of Medicine
Miami, Florida
Associate Professor of Medicine
Division of Gastroenterology and Hepatology
Associate Dean for Medical School Admissions
Assistant Dean for Faculty Diversity and Inclusion
University of Maryland School of Medicine
Baltimore, Maryland
Patient Advocate
None of the nonfaculty planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
This activity is intended for gastroenterologists, primary care physicians (PCPs), nurses, and other healthcare providers (HCPs) involved in the management of patients with inflammatory bowel disease (IBD).
The goal of this activity is to improve HCPs' knowledge and competence related to inequalities in delivery of care among racial and ethnic minorities with IBD, and strategies for alleviating these inequalities.
Upon completion of this activity, participants will:
In accordance with the ACCME’s Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 24 months. The AGA Institute implements a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.
Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Director, Crohn's & Colitis Center
Professor of Medicine
Professor of Microbiology and Immunology
Vice Chair for Research, Department of Medicine
Chair, IOIBD
University of Miami Miller School of Medicine
Miami, Florida
Assistant Professor of Medicine
Director of Translational Studies for the Crohn's and Colitis Center
Division of Gastroenterology
University of Miami Miller School of Medicine
Miami, Florida
Associate Professor of Medicine
Division of Gastroenterology and Hepatology
Associate Dean for Medical School Admissions
Assistant Dean for Faculty Diversity and Inclusion
University of Maryland School of Medicine
Baltimore, Maryland
Patient Advocate
None of the nonfaculty planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.
This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.
Developed through a collaboration between Medscape and American Gastroenterological Association (AGA).
The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AGA Institute designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Awarded 0.50 contact hour(s) of continuing nursing education for RNs and APNs; 0 contact hours are in the area of pharmacology.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of
continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the
time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the
valid credit period that
is noted on the title page. To receive
AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in
your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as
the certificates from the
CME/CE Tracker.
*The credit that you receive is based on your user profile.
CME / CE Released: 12/13/2021
Valid for credit through: 12/13/2022, 11:59 PM EST
processing....
